Munich, Georgia

Daniel Haerle

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Haerle

Introduction

Daniel Haerle is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmacology through his innovative research and development efforts. His work focuses on the preparation of compounds that have valuable therapeutic properties.

Latest Patents

Daniel Haerle holds a patent for a process for the preparation of acylguanidines and acylthioureas. This invention relates to a novel process for creating compounds of general formula (I) and their salts, particularly physiologically acceptable salts with inorganic or organic acids and bases. These compounds exhibit valuable pharmacological properties, especially an inhibitory effect on epithelial sodium channels. This innovation has potential applications in treating diseases, particularly those affecting the lungs and airways. He has 1 patent to his name.

Career Highlights

Daniel Haerle is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves extensive research and development in the field of drug formulation and therapeutic applications. His work has contributed to advancements in medical treatments and has the potential to improve patient outcomes.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues such as Joerg Kley and Guenter Linz. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Daniel Haerle's contributions to the field of pharmacology through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments, particularly for respiratory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…